过去一年中添加的文章,按日期排序

[HTML][HTML] Cardiovascular Disease With Hormone Therapy and Ovarian Suppression in Premenopausal Breast Cancer Survivors

EJ Polter, AE Prizment, RF Walker, Z Ryan… - JACC …, 2024 - Elsevier
2 天前 - … suppression to improve outcomes in premenopausal patients with breast cancer.
Cardiovascular impacts of these treatments among premenopausal women are unknown. …

Association between processed and ultra-processed food intake and the risk of breast cancer: a case-control study

M Nouri, F Mansouri, F Jafari, M Ranjbar Zahedani… - BMC cancer, 2024 - Springer
3 天前 - … the risk of breast cancer in premenopausal women. There … the risk of breast cancer
is stronger in younger women [34]… breast cancer is significant only in premenopausal women

Prevalence of Distant Metastases in High-Risk Operable Breast Cancer (HROBC) pT1-2 N2a or Higher at Diagnosis

V Parmar, NK AN, NS Nair, S Joshi, P Thakkar… - Indian Journal of …, 2024 - Springer
3 天前 - … Forty percent of women were premenopausal, 54 (55.6… women with breast cancer
including those diagnosed at an early stage. The incidence is more common among women

Height and breast cancer risk in premenopausal Korean women aged under 40 years of age

TXM Tran, Y Chang, HR Choi, R Kwon, GY Lim… - … Journal of Cancer, 2024 - nature.com
3 天前 - … associates with breast cancerpremenopausal breast cancer. Therefore, this study
aimed to investigate the association between height and breast cancer risk in Korean women

[HTML][HTML] Macrophages: Key Players in the Battle against Triple-Negative Breast Cancer

I Padzińska-Pruszyńska, P Kucharzewska… - International Journal of …, 2024 - mdpi.com
4 天前 - … TNBC is particularly prevalent in premenopausal African-descent women and is
associated with aggressive tumor behavior and higher metastatic potential. Tumor-associated …

7426 Tamoxifen-Induced Ovarian Hyperstimulation in a Pre-Menopausal Patient with Breast Cancer History: Spontaneous Resolution with Conservative Management

S Gondi, M Contento, A Leiter - Journal of the Endocrine Society, 2024 - academic.oup.com
6 天前 - … of ER-positive breast cancer. Tamoxifen therapy has been reported to increase
serum estrogens and cause ovarian hyperstimulation in premenopausal women, but knowledge …

Reply to C. Fuchao et al

SK Ramchand, E Seeman, R Hoermann… - Journal of Clinical …, 2024 - ascopubs.org
6 天前 - … efficacy of denosumab in preventing bone density and microarchitectural deterioration
in premenopausal women with breast cancer receiving estradiol suppression therapy. …

… the clinical and economic impact of 21-gene oncotype DX® testing in early-stage, 1-3 lymph node-positive, oestrogen receptor-positive, HER2-negative, breast cancer

IM Browne, RA McLaughlin, CS Weadick… - Breast Cancer Research …, 2024 - Springer
7 天前 - … Results from the SWOG S1007 RxPONDER trial suggest that adjuvant chemotherapy
may benefit some premenopausal women with ER-positive, HER2-negative disease with …

[HTML][HTML] Idiopathic Granulomatous Mastitis as a Benign Condition Mimicking Inflammatory Breast Cancer: Current Status, Knowledge Gaps and Rationale for the …

N Krawczyk, T Kühn, N Ditsch, S Hartmann… - Cancers, 2024 - mdpi.com
8 天前 - … pain and ensuing breast deformity. Differentiating IGM from other breast
inflammations caused by infections is essential. IGM mostly affects premenopausal women and is …

Differential benefit of adjuvant everolimus according to endocrine therapy backbone in the randomized UNIRAD trial

M Saint-Ghislain, S Chabaud, F Dalenc, D Allouache… - medRxiv, 2024 - medrxiv.org
8 天前 - premenopausal patients with high-risk early breast cancer, were not available 23,
and tamoxifen alone was considered the standard of care for premenopausal women. Since …